Graft-versus-host disease after liver transplantation: successful treatment of a case.
Graft-versus-host disease (GVHD) is a rare, serious complication after liver transplantation. The incidence is about 1% abroad, but because of difficulties in diagnosis and treatment, the mortality rate is high (80%). Up to now, 78 patients have been reported to have this complication after liver transplantation worldwide; despite various therapeutic programs, the mortality of GVHD after orthotopic liver transplantation (OLT) is still high. Herein we have reported successful treatment of a case of GVHD after liver transplantation.
Lu
Y
Y
Department of Hepatobiliary Surgery, Affiliated Hospital of Medical College, Qingdao University, Qingdao, People's Republic of China. cloudylucn@126.com
Wu
L Q
LQ
Zhang
B Y
BY
Cao
J Y
JY
D000328:Adult; D006086:Graft vs Host Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000009:adverse effects* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous
D007136:Immunoglobulins; D007166:Immunosuppressive Agents